US OTC Oral Contraceptive Access Could Mirror ‘Patchwork’ Of States’ Limits On Abortion Drug
Executive Summary
While FDA decision on first birth control pill proposed for OTC sales in US should be based entirely on safety and efficacy data, same likely won’t be true for lawmakers in some states, particularly already banning or limiting access to abortions services and medications, say former FDA lawyers.
You may also be interested in...
Age-Restriction Labeling, Behind-The-Counter Sales Likely In HRA's US OTC Contraceptive NDA
“I think the issue is whether it is going to have age restricted labeling, which would be a political issue rather than a medical issue,” says
Political Winds, Like Previous Storms Over US FDA Decisions, Stir Around OTC Contraceptive Proposal
Experts spoke with HBW Insight about potential impact on US contraceptive market from Supreme Court’s decision in Dobbs v. Jackson overturning its 1973 ruling in Roe v. Wade, which was upheld in 1992 ruling in Planned Parenthood v. Casey, stating a woman has a constitutional right to reproductive health services.
Allowing States To Ban Abortion Services Increases Calls For Making Birth Control Available OTC
Supreme Court’s six conservative justices say Constitution doesn’t guarantee a woman’s right to abortion services nor prohibit states from regulating or banning the services. Dissenting liberal members decry decision as erasing women’s constitutional rights.